Obatala Sciences, Inc.

NEW ORLEANS, LA · Founded 2017 · CIK 0001828551 · Biotech · Private

Human-derived hydrogel for organ-on-a-chip cell culture platforms, specifically fat-on-a-chip models

obatalasciences.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$200K
1 Form D · Oct 2020
72 months since last filing
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$200,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1198TATEVA THERAPEUTICS INC.——
1199AIMMAX THERAPEUTICS INC—$200K
1200DMC BIOTECHNOLOGIES, INC.—$47M
1201Obatala Sciences, Inc.—$200K
1202Oncorus, Inc.—$47M
1203Qlaris Bio, Inc.—$42M
1204PLAKOUS THERAPEUTICS, INC.—$185K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Trivia FrazierDirector · Executive Officer
  • Jeffrey GimbleDirector · Executive Officer
  • Xiying GimbleDirector · Executive Officer

Patents

USPTO · 0 granted of 3
  • Biological Scaffolds, Products Containing Biological Scaffolds and Methods of Using the Sameapplication
  • Biological Scaffolds, Products Containing Biological Scaffolds and Methods of Using the Sameapplication
  • Biological Scaffolds, Products Containing Biological Scaffolds And Methods Of Using The Sameapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.